Oxford Nanopore announces that the US Court of Appeals for the Federal
Circuit today upheld the decision of the International Trade Commission
(ITC) in favour of Oxford Nanopore. In a complaint previously filed by
Pacific Biosciences, the ITC had previously ruled that the patents being
asserted against Oxford Nanopore with claims directed towards a method
of single molecule sequencing were limited to template-dependent
The decision was also consistent with a recent decision by the European
Patent Office to revoke Pacific Biosciences’ patent EP3045542 with
claims to a single molecule sequencing process.
“Pacific Biosciences has not succeeded in its strategy to try to
prevent us from selling our real-time, direct sequencing technology,
that can provide a full range of solutions from field-based sequencing
to terabases of ultra long reads in a lab,” said Gordon Sanghera,
The court issued a Rule 36 judgement, which is a unanimous confirmance
of the ITC findings.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190212005730/en/